Fair Value Calculator Fair Value Calculator
EN DE

IXIGO (IXIGO) Fair Value & Analysis

Consumer Cyclical · Market cap ₹95.2B

I IXIGO IXIGO · NSE
Price₹217.07
Fair Value₹29.43
Upside-86.4%
Quality50/100
Watch IXIGO for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹24.04 – ₹34.94

Fair value as of: Jul 3, 2026

From 24 valuation models · updated today

Share price +36.0% over the past month.

Price vs Fair Value (12 months)

₹335.55 ₹151.68 Fair Value ₹29.43 Jul 2025 Jul 2026

12‑month range ₹151.68 – ₹335.55 · fair‑value band ₹24.04 – ₹34.94 · the ₹217.07 price screens above the ₹29.43 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

IXIGO (IXIGO) currently trades at ₹217.07, while our model-based Fair Value estimate is ₹29.43 — implying the stock looks roughly 86.4% overvalued today. We read business quality at 50/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, IXIGO generated revenue of ₹12.3B at a net margin of 5.9%. Revenue grew 8.4% year over year. It earns a return on equity of 5.3%. The stock trades on a trailing P/E of 126.9. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹12.3B
Revenue growth (YoY) +8.4%
Net margin 5.9%
Return on equity 5.3%
Free cash flow ₹1.8B FY2026
P/E ratio 126.9
More key figures
Operating margin 6.6%
EPS (TTM) ₹1.71
EPS growth (YoY) +67.4%

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

IXIGO reported revenue of ₹12.3B in FY2026 versus ₹3.8B in FY2022, a compound +34.1%/yr. Reported net income was ₹721M in FY2026.

Revenue +34.1%/yr
FY22 ₹3.8B
FY23 ₹5.0B
FY24 ₹6.6B
FY25 ₹9.1B
FY26 ₹12.3B
Net income
FY22 −₹244M
FY23 ₹216M
FY24 ₹758M
FY25 ₹602M
FY26 ₹721M

Is IXIGO fairly valued? → Check now

Similar stocks

6 more Travel Services stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock Price Fair Value vs Fair Value
Booking Holdings BKNG C$28.09 C$16.76 -40%
Airbnb, Inc ABNB C$23.33 C$10.94 -53%
Royal Caribbean Cruises Ltd RCL $268.73 $140.14 -48%
Viking Holdings VIK $103.05 $61.24 -41%
Carnival Corporation CCL $28.72 $34.66 +21%
Trip.com Group 9961 HK$353.00 HK$676.71 +92%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is IXIGO (IXIGO) undervalued?
As of Jul 3, 2026, our model estimates a fair value of ₹29.43 versus a price of ₹217.07 — about −86% (overvalued). Model-based estimate, not financial advice.
What is the fair value of IXIGO?
Our model-based fair value for IXIGO is ₹29.43 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹217.07.
What is the quality score of IXIGO?
IXIGO has a Quality Score of 50/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of IXIGO (IXIGO)?
IXIGO reported trailing-twelve-month revenue of about ₹12.3B (latest available figure, as of Jul 3, 2026).
What is the net profit margin of IXIGO?
The net profit margin of IXIGO is about 5.9%, meaning it keeps roughly 5.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.